Pharmacological management of painful peripheral neuropathies: a systematic review

A Liampas, M Rekatsina, A Vadalouca, A Paladini… - Pain and Therapy, 2021 - Springer
Introduction Peripheral neuropathic pain (PNP) arises either acutely or in the chronic phase
of a lesion or disease of the peripheral nervous system and is associated with a notable …

Non-pharmacological management of painful peripheral neuropathies: a systematic review

A Liampas, M Rekatsina, A Vadalouca, A Paladini… - Advances in …, 2020 - Springer
Introduction Peripheral neuropathic pain (PNP) is defined as the neuropathic pain that
arises either acutely or in the chronic phase of a lesion or disease affecting the peripheral …

Systematic review and meta‐analysis of pharmacological therapies for painful diabetic peripheral neuropathy

SJ Snedecor, L Sudharshan, JC Cappelleri… - Pain …, 2014 - Wiley Online Library
Background Painful diabetic peripheral neuropathy (pDPN) is prevalent among persons with
diabetes and increases over time. Published guidelines recommend a number of …

[PDF][PDF] Relative efficacy and safety of pharmacotherapeutic interventions for diabetic peripheral neuropathy: a systematic review and bayesian network meta-analysis

MM Asrar, S Kumari, BC Sekhar, A Bhansali… - Pain …, 2021 - academia.edu
Background: Diabetic peripheral neuropathy (DPN) is a most common devitalizing
complication of diabetes mellitus, which is primarily characterized by sensory loss …

Pharmacologic management of diabetic peripheral neuropathic pain

S Iyer, RJ Tanenberg - Expert opinion on pharmacotherapy, 2013 - Taylor & Francis
Introduction: Diabetic peripheral neuropathic pain (DPNP) is a debilitating and distressing
complication that occurs in patients with diabetes mellitus. This article provides an overview …

Management of painful diabetic neuropathy: guideline guidance or jungle?

V Spallone - Current diabetes reports, 2012 - Springer
The treatment of painful diabetic polyneuropathy (PDPN) remains a major challenge. A
number of reasons have made the guidelines on PDPN management of particular interest …

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the …

S Tesfaye, G Sloan, J Petrie, D White, M Bradburn… - The Lancet, 2022 - thelancet.com
Background Diabetic peripheral neuropathic pain (DPNP) is common and often distressing.
Most guidelines recommend amitriptyline, duloxetine, pregabalin, or gabapentin as initial …

Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain

S Quilici, J Chancellor, M Löthgren, D Simon, G Said… - BMC neurology, 2009 - Springer
Background Few direct head-to-head comparisons have been conducted between drugs for
the treatment of diabetic peripheral neuropathic pain (DPNP). Approved or recommended …

Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy

Z Iqbal, S Azmi, R Yadav, M Ferdousi, M Kumar… - Clinical …, 2018 - Elsevier
Purpose Diabetic peripheral neuropathy (DPN) is the commonest cause of neuropathy
worldwide, and its prevalence increases with the duration of diabetes. It affects …

Painful diabetic peripheral neuropathy: practical guidance and challenges for clinical management

FG Preston, DR Riley, S Azmi… - … , Metabolic Syndrome and …, 2023 - Taylor & Francis
Painful diabetic peripheral neuropathy (PDPN) is present in nearly a quarter of people with
diabetes. It is estimated to affect over 100 million people worldwide. PDPN is associated …